|Bid||3.64 x 1300|
|Ask||9.06 x 800|
|Day's Range||8.83 - 9.12|
|52 Week Range||7.37 - 14.61|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||129.29|
|Earnings Date||Nov 23, 2023 - Nov 28, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.17|
Key Insights Using the 2 Stage Free Cash Flow to Equity, Enfusion fair value estimate is US$12.93 Enfusion's US$9.11...
NEW YORK & LONDON & HONG KONG, September 18, 2023--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, announced today that on September 15, 2023, it entered into a new $100 million revolving credit facility. The lenders under the credit facility are primarily a syndicate of Enfusion’s relationship banks, including Bank of America, N.A. The credit facility matures on September 15, 2028 and includes an accord
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...